Sulfasalazine Attenuates Staphylococcal Enterotoxin B-Induced Immune Responses
AbstractStaphylococcal enterotoxin B (SEB) and related exotoxins are important virulence factors produced by Staphylococcus aureus as they cause human diseases such as food poisoning and toxic shock. These toxins bind directly to cells of the immune system resulting in hyperactivation of both T lymphocytes and monocytes/macrophages. The excessive release of proinflammatory cytokines from these cells mediates the toxic effects of SEB. This study examined the inhibitory activities of an anti-inflammatory drug, sulfasalazine, on SEB-stimulated human peripheral blood mononuclear cells (PBMC). Sulfasalazine dose-dependently inhibited tumor necrosis factor α, interleukin 1 (IL-1) β, IL-2, IL-6, interferon γ (IFNγ), and various chemotactic cytokines from SEB-stimulated human PBMC. Sulfasalazine also potently blocked SEB-induced T cell proliferation and NFκB activation. These results suggest that sulfasalazine might be useful in mitigating the toxic effects of SEB by blocking SEB-induced host inflammatory cascade and signaling pathways. View Full-Text
A printed edition of this Special Issue is available here.
Share & Cite This Article
Krakauer, T. Sulfasalazine Attenuates Staphylococcal Enterotoxin B-Induced Immune Responses. Toxins 2015, 7, 553-559.
Krakauer T. Sulfasalazine Attenuates Staphylococcal Enterotoxin B-Induced Immune Responses. Toxins. 2015; 7(2):553-559.Chicago/Turabian Style
Krakauer, Teresa. 2015. "Sulfasalazine Attenuates Staphylococcal Enterotoxin B-Induced Immune Responses." Toxins 7, no. 2: 553-559.